Good morning. Elizabeth Cooney here again at STAT’s home in Boston, filling in for Ed Silverman who’s still in California, no doubt daydreaming about weekend plans. Some biopharma news to start the day:

After months of consideration, Louisiana officials are proceeding with plans for a “Netflix” payment model for obtaining hepatitis C treatments at an affordable price, STAT says. The state is seeking drug makers willing to supply treatments in return for subscription-based payments over five years for unlimited access to medication for anyone who is enrolled in the state Medicaid program or incarcerated in a state prison.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Ms. Cooney – thank you for this “Little” serving of the morning news. While implying that “mr ed” is ‘California Dreaming on such a Winters day’ out here in the East? (Cue the music …. )

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy